Sugarloaf Wealth Management’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-750
| Closed | -$4.97K | – | 710 |
|
|
2022
Q4 | $4.97K | Buy |
750
+500
| +200% | +$3.31K | ﹤0.01% | 581 |
|
|
2022
Q3 | $4K | Hold |
250
| – | – | ﹤0.01% | 631 |
|
|
2022
Q2 | $4K | Buy |
250
+175
| +233% | +$2.8K | ﹤0.01% | 609 |
|
|
2022
Q1 | $3K | Hold |
75
| – | – | ﹤0.01% | 600 |
|
|
2021
Q4 | $4K | Hold |
75
| – | – | ﹤0.01% | 601 |
|
|
2021
Q3 | $8K | Hold |
75
| – | – | ﹤0.01% | 532 |
|
|
2021
Q2 | $7K | Hold |
75
| – | – | ﹤0.01% | 544 |
|
|
2021
Q1 | $8 | Hold |
75
| – | – | ﹤0.01% | 515 |
|
|
2020
Q4 | $7K | Buy |
+75
| New | +$7K | ﹤0.01% | 502 |
|